2 completed, 2 recruiting. 4 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Recruiting 2 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Membranous Nephropathy: new trials by email Literature Review of Membranous Nephropathy trials Research Report on Membranous Nephropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination of Rituximab and Cyclosporine in the Treatment of Primary Membranous Nephropathy Rituximab combined with cyclosporine, rituximab - Membranous Nephropathy | Phase 2 / Phase 3 | Recruiting | Peking University First Hospital | 90 | 2026-01-21 | 2026-10-06 |
| Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX) RiTUXimab Injection - Membranous Nephropathy | Phase 3 | Recruiting | Centre Hospitalier Universitaire de Nice | 120 | 2025-02-04 | 2026-06-22 |
| Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy TACROLIMUS, RITUXIMAB, METHYLPREDNISOLONE - MEMBRANOUS NEPHROPATHY | Phase 3 | Completed | Hospital Universitario 12 de Octubre | 86 | 2014-01-01 | 2020-01-18 |
| Rituximab in Membranous Nephropathy Rituximab - Membranous Nephropathy | Phase 2 / Phase 3 | Completed | Mayo Clinic | 15 | 2004-08-01 | 2011-02-25 |
Glomerulonephritis, Membranous (4)
Autoimmune Diseases (4) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Glomerulonephritis (4) · Immune System Diseases (4) · Kidney Diseases (4) · Male Urogenital Diseases (4) · Nephritis (4) · Urogenital Diseases (4) · Urologic Diseases (4)
Rituximab (4) · Cyclophosphamide (1) · Cyclosporine (1) · Methylprednisolone (1) · Tacrolimus (1)
Centre Hospitalier Universitaire de Nice (1) · Hospital Universitario 12 de Octubre (1) · Mayo Clinic (1) · Peking University First Hospital (1)
China (1) · France (1) · Spain (1) · United States (1)
Fernando C. Fervenza, M.D., Ph.D. (1)